3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Breast Neoplasms
44
Neoplasms
43
Lung Neoplasms
28
Colorectal Neoplasms
21
Carcinoma, Non-Small-Cell Lung
20
Prostatic Neoplasms
15
Ovarian Neoplasms
15
Pancreatic Neoplasms
13
Melanoma
11
Uterine Cervical Neoplasms
10
Neoplastic Cells, Circulating
9
Neoplasm Metastasis
9
Sarcoma
8
Multiple Myeloma
8
Head and Neck Neoplasms
8
Glioma
8
Glioblastoma
8
Hematologic Neoplasms
7
Colonic Neoplasms
7
Lymphoma
6
Leukemia, Myeloid, Acute
6
Carcinoma, Hepatocellular
6
Squamous Cell Carcinoma of Head and Neck
5
Gastrointestinal Neoplasms
5
Endometrial Neoplasms
5
Disease
5
Brain Neoplasms
5
Urinary Bladder Neoplasms
4
Rectal Neoplasms
4
Peritoneal Neoplasms
4
Interventions
fludarabine
2
Cyclophosphamide
2
zanubrutinib
1
pegfilgrastim
1
obinutuzumab
1
fludarabine phosphate
1
Specimen Handling
1
Resistance Training
1
Radiotherapy
1
Neuropsychological Tests
1
Modafinil
1
Magnetic Resonance Spectroscopy
1
Lenalidomide
1
Injections
1
Filgrastim
1
Contrast Media
1
Blood Specimen Collection
1
Azacitidine
1
Alemtuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Lymphoma, B-Cell
×
Blood Specimen Collection
×
Clear all
NCT03787056
2021-07-16
ONCOPRO
Hospices Civils de Lyon
Phase NA
Recruiting
410 enrolled